[Subjective well-being and ability to work of hospital staff after SARS-CoV2 immunization with the mRNA vaccine BNT162b2].
Johannes KalbhennThorsten HammerMartin HugDaniel DürschmiedFrederik WenzDaniel SteinmannPublished in: Deutsche medizinische Wochenschrift (1946) (2021)
Vaccination with BNT162B2 frequently leads to side effects, especially after the second dose. Perception of side effects resulted in 19 % of those questioned being sick after the second dose. Nevertheless, 95 % of all respondents would choose a coronavirus vaccination again.